Belpointe Asset Management LLC - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 25 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q1 2018. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
Belpointe Asset Management LLC ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q1 2018$17,000
-32.0%
30,787
-3.3%
0.01%0.0%
Q4 2017$25,00031,8440.01%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q1 2018
NameSharesValueWeighting ↓
FIRST FOUNDATION ADVISORS 50,000$90,0000.01%
FIRST MIDWEST BANK TRUST DIVISION 16,120$29,0000.01%
Nine Chapters Capital Management LLC 12,900$23,0000.00%
BANK OF AMERICA CORP /DE/ 6$00.00%
WELLS FARGO & COMPANY/MN 1,027$2,0000.00%
GROUP ONE TRADING, L.P. 12,109$22,0000.00%
1832 Asset Management L.P. 10,012$18,0000.00%
TORONTO DOMINION BANK 34$00.00%
DEUTSCHE BANK AG\ 117,727$213,0000.00%
MORGAN STANLEY 59,700$109,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders